3M Scotch-Weld Structural Adhesive Film AF 147

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Acute Toxicity (oral): Category 4. Reproductive Toxicity: Category 1B. Reproductive Toxicity: Lactation. Germ Cell Mutagenicity: Category 2. Specific Target Organ Toxicity (single exposure): Category 1. Specific Target Organ Toxicity (repeated exposure): Category 1.

Hazard pictograms

Exclamation mark | Health Hazard |

Hazard statements

Harmful if swallowed. May damage fertility or the unborn child. May cause harm to breast-fed children. Suspected of causing genetic defects. Causes damage to organs: blood or blood-forming organs | liver | Causes damage to organs through prolonged or repeated exposure: blood or blood-forming organs | liver | May cause damage to organs through prolonged or repeated exposure: nervous system |

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Avoid contact during pregnancy/while nursing. Wear protective gloves. Do not eat, drink or smoke when using this product. Wash thoroughly after handling.

Response

Rinse mouth. IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. IF exposed or concerned: Get medical advice/attention. Specific treatment (see Notes to Physician on this label).

Storage

Store locked up.

Disposal

Dispose of contents/container in accordance with applicable local/regional/national/international regulations. Notes to Physician: Overexposure to this product may result in methemoglobinemia. Methemoglobinemia may be clinically suspected by the presence of clinical "cyanosis" in the presence of a normal PaO2 (as obtained by arterial blood gases). Routine pulse oximetry may be inaccurate for monitoring oxygen saturation in the presence of methemoglobinemia, and should not be used to make the diagnosis of this disorder. If the patient is symptomatic or if the methemoglobin level is >20%, specific therapy with methylene blue should be considered as part of the medical management. 50% of the mixture consists of ingredients of unknown acute oral toxicity. 50% of the mixture consists of ingredients of unknown acute dermal toxicity.